{"id":"https://openalex.org/W2603396766","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.8092","title":"Phase I/II study of rilotumumab (R) and erlotinib (E) in previously treated patients (pts) with metastatic NSCLC.","display_name":"Phase I/II study of rilotumumab (R) and erlotinib (E) in previously treated patients (pts) with metastatic NSCLC.","publication_year":2015,"publication_date":"2015-05-20","ids":{"openalex":"https://openalex.org/W2603396766","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.8092","mag":"2603396766"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2015.33.15_suppl.8092","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.8092","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2015.33.15_suppl.8092","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020955148","display_name":"Ahmad A. Tarhini","orcid":"https://orcid.org/0000-0002-3193-9702","observed_orcids":["https://orcid.org/0000-0002-3193-9702"]},"institutions":[{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ahmad A. Tarhini","raw_affiliation_strings":["University of Pittsburgh Cancer Institute, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh Cancer Institute, Pittsburgh, PA","institution_ids":["https://openalex.org/I4210128526"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076116902","display_name":"Imran Rafique","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Imran Rafique","raw_affiliation_strings":["University of Pittsburgh Cancer Institute, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh Cancer Institute, Pittsburgh, PA","institution_ids":["https://openalex.org/I4210128526"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103010258","display_name":"Phu N. Tran","orcid":"https://orcid.org/0000-0002-8118-2381","observed_orcids":["https://orcid.org/0000-0002-8118-2381"]},"institutions":[{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Phu Tran","raw_affiliation_strings":["University of Pittsburgh Cancer Institute, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh Cancer Institute, Pittsburgh, PA","institution_ids":["https://openalex.org/I4210128526"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017526826","display_name":"William E. Gooding","orcid":"https://orcid.org/0000-0001-9070-3559","observed_orcids":["https://orcid.org/0000-0001-9070-3559"]},"institutions":[{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William E. Gooding","raw_affiliation_strings":["University of Pittsburgh Cancer Institute, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh Cancer Institute, Pittsburgh, PA","institution_ids":["https://openalex.org/I4210128526"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082389042","display_name":"Liza Cosca Villaruz","orcid":"https://orcid.org/0000-0001-7456-523X","observed_orcids":["https://orcid.org/0000-0001-7456-523X"]},"institutions":[{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Liza Cosca Villaruz","raw_affiliation_strings":["University of Pittsburgh Cancer Institute, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh Cancer Institute, Pittsburgh, PA","institution_ids":["https://openalex.org/I4210128526"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043862738","display_name":"Timothy Francis Burns","orcid":"https://orcid.org/0000-0002-8685-3762","observed_orcids":["https://orcid.org/0000-0002-8685-3762"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]},{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy Francis Burns","raw_affiliation_strings":["University of Pittsburgh Cancer Inst, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh Cancer Inst, Pittsburgh, PA","institution_ids":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079001396","display_name":"David Friedland","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Friedland","raw_affiliation_strings":["Division of Hematology/Oncology, University of Pittsburgh, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology, University of Pittsburgh, Pittsburgh, PA","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048553622","display_name":"Grace R. Tarabay","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134769","display_name":"University of Pittsburgh Medical Center","ror":"https://ror.org/04ehecz88","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098814","https://openalex.org/I4210134769"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Grace R. Tarabay","raw_affiliation_strings":["University of Pittsburgh Medical Center Onc Grp, Beaver, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh Medical Center Onc Grp, Beaver, PA","institution_ids":["https://openalex.org/I4210134769"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034861406","display_name":"Andrew D. Laman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]},{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew D. Laman","raw_affiliation_strings":["University of Pittsburg Medcl Ctr Cancer Ctrs, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburg Medcl Ctr Cancer Ctrs, Pittsburgh, PA","institution_ids":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076415174","display_name":"Dhaval R. Mehta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098814","display_name":"UPMC Health System","ror":"https://ror.org/011htkb76","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098814"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dhaval R. Mehta","raw_affiliation_strings":["UPMC Cancer Center, Monroeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UPMC Cancer Center, Monroeville, PA","institution_ids":["https://openalex.org/I4210098814"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111980987","display_name":"Mathew Sulecki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew Gerard Sulecki","raw_affiliation_strings":["University of Pittsburgh Cancer Institute, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh Cancer Institute, Pittsburgh, PA","institution_ids":["https://openalex.org/I4210128526"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045225602","display_name":"Daniel P. Petro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]},{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel P. Petro","raw_affiliation_strings":["University of Pittsburgh Cancer Inst, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh Cancer Inst, Pittsburgh, PA","institution_ids":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031568279","display_name":"Mark S. Georgiadis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark S. Georgiadis","raw_affiliation_strings":["University of Pittsburgh Cancer Institute, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh Cancer Institute, Pittsburgh, PA","institution_ids":["https://openalex.org/I4210128526"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087885978","display_name":"Kevin M. Kane","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142409","display_name":"UPMC McKeesport","ror":"https://ror.org/0365sd121","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098814","https://openalex.org/I4210134769","https://openalex.org/I4210142409"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin M. Kane","raw_affiliation_strings":["HOA of UPCI, Mckeesport, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HOA of UPCI, Mckeesport, PA","institution_ids":["https://openalex.org/I4210142409"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090273578","display_name":"Sajid M. Peracha","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sajid M. Peracha","raw_affiliation_strings":["University of Pittsburgh Medcl Cancer Ctr At Uniontown, Uniontown, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh Medcl Cancer Ctr At Uniontown, Uniontown, PA","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069551263","display_name":"Kiran K. Rajasenan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kiran K. Rajasenan","raw_affiliation_strings":["University of Pittsburgh Cancer Institute, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh Cancer Institute, Pittsburgh, PA","institution_ids":["https://openalex.org/I4210128526"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066191549","display_name":"Alexis Megaludis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexis Megaludis","raw_affiliation_strings":["University of Pittsburgh Cancer Institute, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh Cancer Institute, Pittsburgh, PA","institution_ids":["https://openalex.org/I4210128526"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Lijun Dai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134769","display_name":"University of Pittsburgh Medical Center","ror":"https://ror.org/04ehecz88","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098814","https://openalex.org/I4210134769"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lijun Dai","raw_affiliation_strings":["UPMC Cancer Center, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UPMC Cancer Center, Pittsburgh, PA","institution_ids":["https://openalex.org/I4210134769"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078629724","display_name":"Mark A. Socinski","orcid":"https://orcid.org/0000-0003-2915-9325","observed_orcids":["https://orcid.org/0000-0003-2915-9325","https://orcid.org/0000-0002-8213-0137"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark A. Socinski","raw_affiliation_strings":["University of Pittsburgh, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh, Pittsburgh, PA","institution_ids":["https://openalex.org/I170201317"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"33","issue":"15_suppl","first_page":"8092","last_page":"8092"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rilotumumab","display_name":"rilotumumab","score":0.9929999709129333},{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":1.0},{"id":"https://openalex.org/keywords/metastatic-nsclc","display_name":"metastatic non-small cell lung cancer","score":0.9810000061988831},{"id":"https://openalex.org/keywords/met-overexpression","display_name":"MET overexpression","score":0.800000011920929},{"id":"https://openalex.org/keywords/hepatocyte-growth-factor","display_name":"hepatocyte growth factor","score":0.9409999847412109},{"id":"https://openalex.org/keywords/egfr-inhibitor-resistance","display_name":"EGFR inhibitor resistance","score":0.8399999737739563},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.746999979019165},{"id":"https://openalex.org/keywords/dose-de-escalation","display_name":"dose de-escalation","score":0.7379999756813049},{"id":"https://openalex.org/keywords/recommended-phase-ii-dose","display_name":"recommended phase 2 dose","score":0.9079999923706055},{"id":"https://openalex.org/keywords/disease-control-rate","display_name":"disease control rate","score":0.9070000052452087},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8920000195503235},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6380000114440918},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.7070000171661377},{"id":"https://openalex.org/keywords/previously-treated-patients","display_name":"previously treated patients","score":0.8240000009536743},{"id":"https://openalex.org/keywords/kras-mutation","display_name":"KRAS mutation","score":0.6299999952316284},{"id":"https://openalex.org/keywords/egfr-mutation","display_name":"EGFR mutation","score":0.9010000228881836}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9215824007987976},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6146273612976074},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.520839512348175},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5043340921401978},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.48710131645202637},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.45315879583358765},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.4266052544116974},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3797532320022583},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.35548990964889526},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.25790104269981384},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.15856561064720154},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.09129273891448975}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2015.33.15_suppl.8092","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.8092","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2015.33.15_suppl.8092","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2804471275","https://openalex.org/W1483707553","https://openalex.org/W2619172668","https://openalex.org/W3030972949","https://openalex.org/W2048789336","https://openalex.org/W2150724094","https://openalex.org/W2006763848","https://openalex.org/W2112866395","https://openalex.org/W2137376225","https://openalex.org/W4238006225"],"abstract_inverted_index":{"8092":[0],"Background:":[1],"MET":[2,10],"is":[3,23,61,400],"frequently":[4],"overexpressed":[5],"in":[6,373],"NSCLC.":[7],"Amplification":[8],"of":[9,17,44,146,175,178,189,209,253,283,292,312,326,369,397],"and":[11,38,58,88,172,237,242,268,275,290,358,371,384],"its":[12],"ligand":[13],"(HGF),":[14],"are":[15],"mechanisms":[16],"resistance":[18],"to":[19,64,106,135,163,183,378],"EGFR":[20,241,267],"inhibitors.":[21],"R":[22,45,79,370],"an":[24,380],"IgG2":[25],"human":[26],"mAb":[27],"that":[28,341],"targets":[29],"HGF.":[30],"This":[31],"phase":[32,40],"I/II":[33],"trial":[34,403],"evaluated":[35],"the":[36,121,124,165,207,214,218,385,389],"safety":[37,382],"recommended":[39],"2":[41,158,240],"dose":[42,75,98,113,125,223],"(RP2D)":[43],"combined":[46],"with":[47,51,78,127,230,266],"E":[48,89,149,195,372],"for":[49,148,169,187,211,279,393],"pts":[50,180,229,261],"metastatic":[52],"previously":[53],"treated":[54],"NSCLC":[55],"(Phase":[56,68],"I)":[57],"whether":[59,137],"efficacy":[60],"high":[62],"enough":[63],"warrant":[65],"further":[66],"interest":[67],"II).":[69],"Methods:":[70],"Phase":[71,132],"I":[72,171],"adopted":[73],"a":[74,111,128,190,280,308],"de-escalation":[76,99,212],"design":[77,109,160],"starting":[80],"at":[81,344],"15":[82,313],"mg/kg":[83],"IV":[84,232],"every":[85,202],"3":[86],"weeks":[87],"150":[90],"mg":[91],"orally":[92],"daily":[93],"(dose":[94],"level":[95,224],"0).":[96],"If":[97],"was":[100,114,120,161,198,220,248,317,330,376],"needed":[101],"it":[102],"would":[103],"proceed":[104],"according":[105],"Narayana":[107],"k-in-a-row":[108],"where":[110],"selected":[112],"estimated":[115],"by":[116,153,200],"isotonic":[117],"regression.":[118],"RP2D":[119,219],"maximum":[122],"below":[123],"associated":[126],"25%":[129],"DLT":[130],"rate.":[131],"II":[133,173],"intended":[134],"test":[136],"disease":[138,142,185],"control":[139,186],"rate":[140,282,387],"(stable":[141],"or":[143],"response,":[144],"DCR)":[145],"50%":[147],"could":[150],"be":[151],"improved":[152],"adding":[154],"R.":[155],"A":[156,251],"Simon":[157],"stage":[159,231],"used":[162],"select":[164],"optimal":[166],"sample":[167],"size":[168],"type":[170],"error":[174],".10.":[176],"Twenty-seven":[177],"45":[179,227],"were":[181,233,258,342,348],"required":[182],"have":[184,379],"evidence":[188],"statistically":[191],"significant":[192],"improvement":[193],"over":[194],"alone.":[196],"Response":[197],"assessed":[199],"RECIST":[201],"6":[203],"weeks.":[204],"Results:":[205],"In":[206],"absence":[208],"need":[210],"among":[213],"first":[215],"8":[216],"pts,":[217],"defined":[221],"as":[222],"0.":[225],"Overall,":[226],"response-evaluable":[228],"enrolled":[234],"(13":[235],"squamous":[236],"32":[238],"adenocarcinoma;":[239],"7":[243],"KRAS":[244,270],"mutant).":[245],"Median":[246,299],"age":[247],"65":[249],"years.":[250],"median":[252,309,315],"4":[254],"cycles":[255],"(range":[256],"1-18+)":[257],"administered.":[259],"Four":[260],"had":[262,273,277],"partial":[263],"response":[264,281],"(one":[265],"one":[269,328],"mutation),":[271],"23":[272],"SD,":[274],"18":[276],"progression,":[278],"8.9%":[284],"(90%":[285,294,303,320,332],"CI,":[286,295,321,333],"3.9":[287],"-":[288,297,323,335],"18.1)":[289],"DCR":[291,386],"60%":[293],"47.1":[296],"71.3).":[298],"PFS":[300],"2.6":[301],"months":[302,319],"CI":[304],"1.4-":[305],"2.7).":[306],"At":[307],"follow":[310],"up":[311],"months,":[314],"OS":[316],"6.6":[318],"5.6":[322],"8.9).":[324],"Probability":[325],"surviving":[327],"year":[329],".33":[331],".23":[334],".47).":[336],"Among":[337],"grade":[338],"3/4":[339],"AEs":[340],"considered":[343],"least":[345],"possibly":[346],"related":[347],"rash":[349],"(3),":[350,363],"oral":[351],"mucositis":[352],"(1),":[353,360],"elevated":[354],"alkaline":[355],"phosphatase":[356],"(3)":[357],"bilirubin":[359],"thromboembolic":[361],"event":[362],"diarrhea":[364],"(5).":[365],"Conclusions:":[366],"The":[367],"combination":[368],"this":[374,398],"study":[375],"found":[377],"acceptable":[381],"profile":[383],"met":[388],"study\u2019s":[390],"pre-specified":[391],"criteria":[392],"success.":[394],"Further":[395],"investigation":[396],"regimen":[399],"warranted.":[401],"Clinical":[402],"information:":[404],"NCT01233687.":[405]},"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2025-10-10T00:00:00"}